Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxici...
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies, has been approved for the treatment of relapsed or refractory multiple myeloma and other cancers. Recently, bortezomib has been identified as an effective inhibitor of neuroblastoma cell growth and angiogenesis.
In t...
Alternative Titles
Full title
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e489e57953b14e949d3feff1f8fe4019
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e489e57953b14e949d3feff1f8fe4019
Other Identifiers
ISSN
1476-4598
E-ISSN
1476-4598
DOI
10.1186/1476-4598-7-50
